Print version ISSN 0004-282X
Arq. Neuro-Psiquiatr. vol.70 no.8 São Paulo Aug. 2012
Distonia isolada dos músculos frontal, corrugador e prócero - uma variante de blefaroespasmo
Giorgio FabianiI; Renato Puppi MunhozII; Hélio A. G. TeiveII
INeurology Service of Hospital das Nações, Curitiba PR, Brazil
IIMovement Disorders Unit, Neurology Service, Federal University of Paraná (UFPR), Curitiba PR, Brazil
Blepharospasm (BSM) is a form of cranial dystonia caused by involuntary bilateral eye closure produced by contractions of orbicularis oculi muscles, often accompanied by dystonic movements of the eyebrows, paranasal, facial, masticatory, labial, lingual, oral, pharyngeal, laryngeal and cervical muscles1-3. In most instances, BSM is idiopathic. However, cases associated with lesions in rostral brainstem or other parts of basal ganglia (multiple sclerosis, stroke, thalamotomy and autoimmune disorders) have been described 1,3,4. BSM is more common in females (3:1 rate) and, in almost three quarters of all cases, after the age of 59 years1,4.
We report an unusual form of focal dystonia, affecting the frontalis, corrugator and procerus muscles, without any involvement of orbicularis oculi muscles that characterizes BSM.
A 46-year-old Afro-South American male was initially evaluated due to a complaint of mild involuntary forehead muscle movements, leading to significant physical and psychological discomfort. The patient presented the symptoms since childhood, and the intensity of the contractions worsened until the age of 35 years, remaining relatively stable since then. Neurological examination showed symmetrical involuntary movements of frontalis, corrugator and procerus muscles, completely sparing the orbicularis oculi muscles. Additionally, he presented upward oculogyric deviations (Figure). The movement disorder disappeared when his eyes were closed and returned immediately after opening them. There were historic or clinical data suggestive of a tic disorder. Laboratory tests and cranial CT and MRI scans were unremarkable. Initially, he was treated with flufenazine, haloperidol and clonazepam with no clinical effect, as a differential diagnosis of tic disorder was made.
Our next approach was for intramuscular botulinum toxin type A injections. After informed consent was obtained, a total dose of 100/IU botulinum toxin type A (Dysport, Ipsen, UK) was injected in the frontalis, corrugator and procerus muscles. On a three-week follow-up, the dystonic symptoms and signs were completely abolished.
BSM is relatively uncommon in men, especially before the age of 50 years. Its hallmark is the involvement of the orbicularis oculi muscles that is essential for the diagnosis. This partially explains the difficulties we found in regards to the differential diagnosis of the movement in this patient as he presented the symptoms since childhood. The main differential diagnosis of our case was simple chronic motor tic although was no evident premonitory phenomenon. The abnormal movements were neither intermittent, repetitive nor abrupt. Additionally, there was no supressibility and response to the traditional treatment.
Nonetheless these unusual features, we assumed the possibility of an unusual presentation of cranial dystonia with sole bilaterally involvement of frontalis, corrugator and procerus muscles. We believe that the upward eye deviations were a sensory trick that transiently relieved the involuntary movements.
We also highlight the fact that this unusual presentation of dystonia is almost indistinguishable from essential BSM, except by the non-involvement of the orbicularis oculi muscles.
To best of our knowledge, this is the first report of sole frontalis, corrugator and procerus dystonia. Recently, Hirota et al.5 reported two cases of dystonic frowning. The first patient presented involuntary frowning and grimacing as the sole symptom, with no eyelid involvement. The second had typical symptoms of BSM only in the early phase of the disease, later the pattern of contractions changed and involuntary frowning and grimacing predominated. As most focal dystonias, these cases also presented excellent response to the use of botulinum toxin type A.
1. Fahn S, Bressman SB, Marsden CD. Classification of dystonia. Adv Neurol 1998;78:1-10 [ Links ]
2. Frucht S, Fahn S, Ford B, Gelb M. A geste antagoniste device to treat jaw-closing dystonia. Mov Disord 1999;14:883-886. [ Links ]
3. Lindeboom R, de Haan R, Aramideh M, Speelman JD. The blepharospasm disability scale: an instrument for the assessment of functional health in blepharospasm. Mov Disord 1995;10:444-449. [ Links ]
4. Jankovic J. Blepharospasm and basal ganglia lesions. Arch Neurol 1986;43:866-868. [ Links ]
5. Hirota N, Hirota M, Mezaki T. Dystonic frowning without blepharospasm. Parkinsonism Relat Disord 2008;14:579-580. [ Links ]
Received 19 December 2011
Received in final form 01 March 2012
Accepted 08 March 2012
Conflict of interest: There is no conflict of interest to declare.